Latest Trading Suspensions News

NeuRizer Ltd has advanced its NeuRizer Urea Project with key environmental approvals and construction plans, while raising $350,000 through private placements. However, the company faces a trading suspension as it works to resolve audit and compliance issues with the ASX.

State Gas Limited has decided against proceeding with the sale of its High Density Natural Gas Pilot Plant after failing to finalise terms, while its R&D tax incentive claim remains under extended review by the ATO.

State Gas Limited has voluntarily suspended trading on the ASX as it finalises negotiations on a significant asset sale and clarifies related R&D incentive claims. The suspension will last until an announcement expected by 30 March 2026.

Peppermint Innovation Limited reported a $1.27 million net loss for the half-year ending December 2025 while achieving key milestones including activation of national payment rails in the Philippines and settling a statutory demand that led to an ASX trading suspension.

ASX Compliance has formally queried Reckon Limited regarding a late filing of a director interest notice, raising potential breaches of key listing rules. The company must respond swiftly to avoid trading disruptions.

After an 18-month trading suspension, Lithium Energy Limited has resumed ASX trading, unveiling a diversified portfolio including new gold-copper and lithium brine projects alongside a strategic graphite acquisition.

ARC Funds Limited’s trading suspension has been lifted following key announcements about new board appointments, signaling a fresh chapter for the investment manager.

WA Kaolin Limited reported a $5.06 million half-year loss despite a 257% revenue surge, grappling with operational setbacks and regulatory challenges. The company’s recent debt restructuring and trading suspension signal a critical juncture as it seeks to stabilise and recapitalise.

NeuRizer Limited has secured a pivotal partnership with Reliance Industries, enabling it to resolve funding challenges and accelerate its Leigh Creek urea project. This collaboration marks a turning point for the company, allowing it to exit suspension and advance critical regulatory and operational milestones.

Immutep Limited’s shares have resumed trading following the release of an interim futility analysis from its pivotal TACTI-004 Phase III trial of eftilagimod alfa.

Immutep Limited has voluntarily suspended trading of its shares on the ASX pending the release of a key announcement regarding the interim futility analysis of its TACTI-004 Phase III trial. The suspension underscores the market’s anticipation of potentially pivotal clinical trial results.

Pearl Gull Iron Limited’s shares have been suspended from ASX trading following the sale of its main asset, the Cockatoo Island Project, as the company works to meet compliance requirements.